Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-05-28

FDA Approved: LOPERAMIDE HYDROCHLORIDE — Supplemental Application (Aurohealth LLC)

View source ↗

Summary

FDA approved a supplemental application for loperamide hydrochloride from Aurohealth LLC under ANDA206548, confirming the regulatory status of the product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Loperamide hydrochloride (LOPERAMIDE HYDROCHLORIDE)

Snippet

SUPPL AP for LOPERAMIDE HYDROCHLORIDE (LOPERAMIDE HYDROCHLORIDE)